(Q38820176)

6 September 2017

Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 September 2017

1 reference

1 reference

1 reference

1 reference

Bing-Hang Li

1

1 reference

6 September 2017

Fang-Ping He

2

1 reference

6 September 2017

Xin Yang

3

1 reference

6 September 2017

Yuan-Wen Chen

4

1 reference

6 September 2017

Jian-Gao Fan

5

1 reference

6 September 2017

31 August 2016

1 reference

6 September 2017

Translational Research

1 reference

6 September 2017

180

1 reference

6 September 2017

103-117.e4

1 reference

Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Present and future therapeutic strategies in non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Role of cytokines and chemokines in non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Steatohepatitis: a tale of two "hits"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Effect of ambrex (a herbal formulation) on oxidative stress in hyperlipidemic rats and differentiation of 3T3-L1 preadipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Activation of nuclear factor kappa B in the hepatic stellate cells of mice with schistosomiasis japonica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Acetic acid treatment for wrinkle-free oral mucosal epithelia in paraffin section preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Induction of cytochrome P450: assessment in an immortalized human hepatocyte cell line (Fa2N4) using a novel higher throughput cocktail assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Palmitate increases the susceptibility of cells to drug-induced toxicity: an in vitro method to identify drugs with potential contraindications in patients with metabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

99mTc-labelled anti-CD11b SPECT/CT imaging allows detection of plaque destabilization tightly linked to inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Effects of Tanshinone IIA on the modulation of miR‑33a and the SREBP‑2/Pcsk9 signaling pathway in hyperlipidemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

PDGF-induced migration of vascular smooth muscle cells is inhibited by heme oxygenase-1 via VEGFR2 upregulation and subsequent assembly of inactive VEGFR2/PDGFRβ heterodimers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Net -1 frameshifting on a noncanonical sequence in a herpes simplex virus drug-resistant mutant is stimulated by nonstop mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Rapid preparation of high-purity nuclear proteins from a small number of cultured cells for use in electrophoretic mobility shift assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Activated effects of parathyroid hormone-related protein on human hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

CCAAT/enhancer binding protein β in relation to ER stress, inflammation, and metabolic disturbances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2016.08.006

10.1016/J.TRSL.2016.08.006

7 January 2021

Identifiers

DOI

1 reference

6 September 2017

1 reference